What is the Projected CAGR value of the Non Small-Cell Lung Cancer Market ?
Non Small-Cell Lung Cancer Market is expected to grow at a CAGR of 8.4% during the forecast period 2023-2030.
Who are the key players in Non Small-Cell Lung Cancer Market?
The major global players in the market include Eli Lilly and Company, Sanofi, Novartis AG, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Pfizer Inc., Astrazeneca, Boehringer Ingelheim, Bristol-Myers Squibb Company, and Astellas among others.
Which region controlled the global market during 2023-2030?
North America region Controls the Non Small-Cell Lung Cancer Market during 2023-2030
Which is the fastest-growing region in the Non Small-Cell Lung Cancer Market Scope?
Among all regions, Asia Pacific is the fastest-growing market share during the forecast period.